Ki Yong Chung1, Jongkyoo Kim2, Bradley J Johnson3. 1. Department of Beef Science, Korea National College of Agriculture and Fisheries, Jeonju 54874, Korea. 2. Department of Animal Science & Food Science and Human Nutrition, Michigan State University, East Lansing, MI 48824, USA. 3. Department of Animal and Food Science, Texas Tech University, Lubbock, TX 79409, USA.
In the current beef industry, intramuscular (IM) fat contents are critical factors in
determining the beef quality and economic value. Increasing days on feed with a
grain-based diet is a common and widely used strategy to maximize the marbling of
beef without modifying the genetics of animals. This feeding strategy can decrease
feed efficiency and increase backfat thickness simultaneously. Since energy costs
increase as the proportion of gain as internal or subcutaneous (SC) fat [1], an increased amount of that adipose tissue
may be less desirable. There have been efforts to increase IM fat intensively
without altering other, economically valueless adipose tissues. With the long-period
selection, Wagyu and Hanwoo cattle showed high-marbling traits with less backfat
thickness while feeding grain-based diets with around 30-month of the feeding
period. At the same time, researchers also have been searching for nutritional
methods to increase IM fat, such as a vitamin A-deficient diet. The long-term
depletion of vitamin A has commonly been used in a few countries to increase IM
adipose tissue accumulation [2]. Multiple
vitamin A isoforms, including 9- cis retinoic acid and all-trans-retinoic acid
reported as an inhibitor of peroxisome proliferator-activated receptor γ
(PPARγ) and retinoid X receptor (RXR). Among various vitamin A isoforms,
all-trans retinoic acid (ATRA) is known to be the most active isoform in mammals. It
has numerous physiological effects such as vision, embryonic development,
reproduction, hematopoiesis, and differentiation of epithelial and mesenchymal
cells. It also reported that dietary vitamin A negatively affects the development of
adipose tissues in mammalian animals [3-5]. Therefore, ATRA has
been chosen as a vitamin A source in the current study. In countries where marbling
is the most important factor for consumer’s beef choice, vitamin A or
provitamin A-deficient diets have been used for beef cattle to maximize IM fat
accumulation [2]. Inhibitory effects of
vitamin A isoforms have been tested with various cell and animal types such as swine
[6], cattle [7], and rodents [8,9]. Nevertheless, much is unknown about the
biological metamorphosis of adipocytes, which have many differences across species
and peripheral adipose depots. Therefore, this study was conducted to determine the
influence of ATRA on genes associated with adipogenic differentiation of bovine SC
and IM adipocytes.
MATERIALS AND METHODS
Primary preadipocytes isolation
IM preadipocytes were isolated from three 16- month- old, crossbred steers
(predominantly Angus, 474.5 ± 50.2 kg). Cattle were harvested in the Meat
Science Laboratory (abattoir) at Texas Tech (Lubbock, TX, USA) under United
States Department of Agriculture (USDA) inspection and exsanguinated following
captive bolt stunning. Bovine IM adipose tissue was collected from between the
10th and 13th rib sections of the longissimus dorsi (LD) muscle
(Fig. 1). SC adipose tissue was
collected from the 10th and 13th rib areas immediately after the skin was
removed. Isolated LD muscle SC adipose tissue and a chunk were promptly
transported to the Texas Tech University Meat Science and Muscle Biology
Laboratory (Lubbock, TX) in cold sterilized phosphate-buffered saline (PBS;
Gibco, Waltham, MA, USA) with 3 × Antibiotic-Antimycotic (Gibco). The IM
fat tissue was dissected from LD, excluding connective tissue, blood vessels,
and skin was removed. Both IM and SC Adipose tissues were minced finely and
incubated in the warm digestion medium, containing Earl’s Balanced Salt
Solution (EBSS, Sigma-Aldrich, St. Louis, MO, USA), 0.1% of type IV collagenase
(Thermo Fisher Science, Waltham, MA, USA), and 1 × Antibiotic-Antimycotic
(Gibco) for 40 minutes at 38°C. The collagenase-digested adipose tissue
was filtered through a 100 μm nylon membrane, and the suspension was then
centrifuged for 5 min at 2,000×G. After discarding the supernatant and
lipid layer, the pellet was washed 3 times in Dulbecco’s Modified Eagle
Medium (DMEM). The pellet was re-suspended and maintained in growth media
composed of DMEM (Gibco), 10% fetal bovine serum (FBS, Gibco), and 1×
Antibiotic-Antimycotic (Gibco) at 37°C under a humidified atmosphere of
5% CO2. Upon reaching approximately 90% confluency, the growth medium
was replaced by differentiation media composed of DMEM (Gibco), 5% FBS (Gibco),
10 μg/mL insulin (Sigma-Aldrich), 10 μg/mL hydrocortisone
(Sigma-Aldrich), 5 μM ciglitizone (Sigma-Aldrich), and 1×
Antibiotic-Antimycotic (Gibco) with doses of 0 (Con), 0.01, 0.1, 0.1, 1
μM, and 10 μM of ATRA (Sigma-Aldrich). In addition to this, 1
μM of retinoic acid receptor (RAR) antagonist (ANT; AGN 193109 sodium
salt, Santa Cruz Biotechnology, Dallas, TX, USA) was used in a dose-dependent
manner, 0 (Con), 0.01, 0.1, 1 μM, and 10 μM for 24 h and 96 h of
incubation.
Fig. 1.
Schematic illustration of cell culture procedure.
Primary cell isolation: the intramuscular (IM) (dissected from LD) and
subcutaneous fat tissue were isolated from three 16- month- old,
crossbred steers, and incubated digestion medium; containing
Earl’s Balanced Salt Solution, 0.1% of type IV collagenase, and 1
× Antibiotic-Antimycotic (Gibco, Waltham, MA, USA) for 40 minutes
at 38°C. Primary cell culture: bovine IM and subcutaneous (SC)
preadipocytes were isolated from a beef steer. Preadipocytes were
incubated in 10% FBS/DMEM with 1 × Antibiotic-Antimycotic upon
reaching 80%–90% confluency. Following that, adipogenic
differentiation was induced by the addition of differentiation media
containing 5% FBS, insulin (10 μg/mL), hydrocortisone (10
μg/mL), ciglitizone (5 μM), and 1 ×
Antibiotic-Antimycotic. Different doses (0, 0.001, 0.01, 0.1, and 1
μM) of all-trans retinoic acid (ATRA) and retinoic acid receptor
(RAR) antagonist (ANT; 1 μM) were added into the differentiation
media. Analysis: After 96 h of incubation with differentiation media,
cells were harvested and used for mRNA gene expression analysis, oil red
O staining (ORO), and immunohistochemistry.
Schematic illustration of cell culture procedure.
Primary cell isolation: the intramuscular (IM) (dissected from LD) and
subcutaneous fat tissue were isolated from three 16- month- old,
crossbred steers, and incubated digestion medium; containing
Earl’s Balanced Salt Solution, 0.1% of type IV collagenase, and 1
× Antibiotic-Antimycotic (Gibco, Waltham, MA, USA) for 40 minutes
at 38°C. Primary cell culture: bovine IM and subcutaneous (SC)
preadipocytes were isolated from a beef steer. Preadipocytes were
incubated in 10% FBS/DMEM with 1 × Antibiotic-Antimycotic upon
reaching 80%–90% confluency. Following that, adipogenic
differentiation was induced by the addition of differentiation media
containing 5% FBS, insulin (10 μg/mL), hydrocortisone (10
μg/mL), ciglitizone (5 μM), and 1 ×
Antibiotic-Antimycotic. Different doses (0, 0.001, 0.01, 0.1, and 1
μM) of all-trans retinoic acid (ATRA) and retinoic acid receptor
(RAR) antagonist (ANT; 1 μM) were added into the differentiation
media. Analysis: After 96 h of incubation with differentiation media,
cells were harvested and used for mRNA gene expression analysis, oil red
O staining (ORO), and immunohistochemistry.
Morphological staining
After 96 h of differentiation, the plates were removed from the incubator and
rinsed three times with PBS. The fixation of IM cells was conducted using 10%
formalin (Sigma-Aldrich) for 10 min. Lipid droplets were stained using a 0.5%
Oil Red O solution (ORO, Sigma-Aldrich) in propylene glycol (Sigma). After 1h of
incubation with ORO solution in a dark room, plates were rinsed with de-ionized
(DI) water. Plates were then stained using Mayer’s hematoxylin
(Sigma-Aldrich) for 20 min to visualize nuclei. All cells were imaged with a
Nikon Eclipse Ti-U microscope (Nikon Instruments, Tokyo, Japan). Images were
processed using NIS-Elements software (Nikon Instruments).
Real time-polymerase chain reaction (PCR) sample preparation and RNA
isolation
Cultured IM and SC preadipocytes were trypsinized (Sigma-Aldrich) and centrifuged
for 5 min at 300×g. Total RNA isolation and purification steps were
performed using the RNeasy® Mini kit (Qiagen, Germantown, MD,
USA) according to manufacturer recommendation. The concentration and purity of
RNA were measured with a spectrophotometer at an absorbance of 260 nm and 280 nm
using a NanoDrop 1000 (NanoDrop Technologies, Wilmington, DE, USA). An
acceptable range of 1.76 to 2.05 was used for the 260/280 ratio. Genomic DNA
removal and cDNA synthesis were conducted using QuantiTect reverse transcription
kit (Qiagen) according to manufacturer recommendations. Real-time quantitative
PCR (7900-HT Real-Time PCR System, Applied Biosystems, Foster City, CA, USA) was
used to measure the quantity of CCAAT/Enhancer binding protein
(C/EBP) β, PPARγ, glucose
transporter 4 (GLUT4), stearoyl CoA
desaturase (SCD), and Smad transcription
factor 3 (SMAD3) relative to the quantity of
ribosomal protein subunit 9 (RPS 9) mRNA
in total RNA (Table 1). Since the
expression of RPS9 did not differ across samples nor
treatments, RPS9 was used as the endogenous control in order to
normalize the expression of genes. Measurement of the relative quantity of the
cDNA of interest was carried out using TAMRA PCR Master Mix (Applied Biosystems)
using the appropriate forward and reverse primers and cDNA mixture. Assays were
performed in triplicate determinations using the thermal cycling parameters
recommended by the manufacturer (40 cycles of 15 s at 95°C and 1 min at
60°C). Titration of mRNA primers against increasing amounts of cDNA
yielded linear responses with slopes between −2.8 and −3.0. The RQ
manager (Applied Biosystems) analyzed real-time quantitative (RQ) values based
on ΔΔCT.
Table 1.
Primer and probe sequences for the gene expression analysis
Genes
Sequence (5’ to
3’)
CEBPβ
Forward
CCAGAAGAAGGTGGAGCAACTG
Reverse
TCGGGCAGCGTCTTGAAC
TaqMan probe
6FAM-CGCGAGGTCAGCACCCTGC-TAMRA
GLUT4
Forward
CCTCGGCAGCGAGTCACT
Reverse
AAACTGCAGGGAGCCAAGAA
TaqMan probe
6FAM-
CCTTGGTCCTTGGCGTATTCTCCGC-TAMRA
PPARγ
Forward
ATCTGCTGCAAGCCTTGGA
Reverse
TGGAGCAGCTTGGCAAAGA
TaqMan probe
6FAM-CTGAACCACCCCGAGTCCTCCCAG-TAMRA
RPS9
Forward
GAGCTGGGTTTGTCGCAAAA
Reverse
GGTCGAGGCGGGACTTCT
TaqMan probe
6FAM-ATGTGACCCCGCGGAGACCCTTC-TAMRA
SCD
Forward
TGCCCACCACAAGTTTTCAG
Reverse
GCCAACCCACGTGAGAGAAG
TaqMan probe
6FAM-CCGACCCCCACAATTCCCG-TAMRA
SMAD3
Forward
CGTCCATCCTGCCTTTCACT
Reverse
TTCTGCTCGCCCTTTTTCC
TaqMan probe
6FAM-CCCGATCGTGAAGCGCCTGCT-TAMRA
C/EBPβ, CCAAT/enhancer-binding protein
β; GLUT4, glucose transporter 4;
PPARγ, peroxisome proliferated activate
receptor γ; RPS9, ribosomal protein subunit
9; SCD, stearoyl CoA desaturase;
SMAD3, SMAD family member 3.
C/EBPβ, CCAAT/enhancer-binding protein
β; GLUT4, glucose transporter 4;
PPARγ, peroxisome proliferated activate
receptor γ; RPS9, ribosomal protein subunit
9; SCD, stearoyl CoA desaturase;
SMAD3, SMAD family member 3.
Immunohistochemistry
Cells were grown on 3-well microscopy glass slides (Ibidi USA, Fitchburg, WI,
USA) for 96 h after inducing differentiation. Slides were fixed with cold 4 %
paraformaldehyde (Thermo Fisher Scientific) for 10 min at room temperature. In
order to prevent nonspecific background staining, fixed cells were incubated in
the blocking solution containing 2% bovine serum albumin (Thermo Fisher
Scientific), 5% of horse serum (Thermo Fisher Scientific), and 0.2% Triton X-100
in PBS for 30 min at room temperature. Fixed cells were then incubated with
primary antibody anti-PPARγ (rabbit polyclonal, dilution 1:100; Abcam,
Cambridge, UK) at 4°C overnight.The colorization of F-actin was conducted using Bodipy (558/568) phalloidin
(Thermo Fisher Scientific) according to the manufacture’s guidance.
Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI, Thermo
Fisher Scientific) for 5 min. Slides were imaged at a magnification of 20X using
an inverted fluorescence microscope (Nikon Eclipse, Ti-E; Nikon Instruments)
equipped with a UV light source (C-HGFIE, Nikon Intensilight, Tokyo, Japan). The
NIS Elements® imaging software analyzed all images.
Statistical analysis
Gene expression data were analyzed as a completely randomized design using the
MIXED procedure of SAS 9.4 (SAS Inst., Cary, NC, USA) using orthogonal contrasts
for the dose-effect analysis. All results were reported as least-squares means.
An α level of 0.05 was used to determine significance, with tendencies
discussed at P-values between 0.05 and 0.10.
RESULTS AND DISCUSSION
IM adipose tissue, also known as marbling fat in the meat industry, displays
distinctive characteristics from other adipose tissues, primarily through their
unique location and cellular level metabolism [4]. IM adipose cells are located within the perimysium alongside
myofibers [10]. Due to its unique location,
it is considered that this adipose tissue may closely communicate with neighboring
muscle cells.
Key transcription factors during adipogenic differentiation
There are two distinctive phases during adipogenesis, which are determination
(proliferation) and differentiation. During the determination period, adipocyte
precursor cells and preadipocytes stay in the cell cycle and increase numbers
through mitosis. While the differentiation process of preadipocytes into mature
adipocytes is well-studied, a large portion of adipogenic determination is still
unknown. Various transcriptional regulation events occur during adipogenic
differentiation. The majority of them are associated mainly with the
PPARγ or C/EBP family, which are
often referred to as key transcription factors [4,11]. Among various C/EBP
isoforms, C/EBPβ plays a crucial role in the early stage of adipogenesis.
In our current study, a high dose of ATRA (10µM) suppressed
(p < 0.05) the expression of
C/EBPβ in SC cells (Fig.
5). Unlike the SC cells, ATRA treatment did not alter
(p > 0.05) the C/EBPβ gene
expression in IM (Fig. 4). The expression
of C/EBPβ is almost simultaneous with the induction of adipogenic
stimuli. C/EBPβ induction leads to PPARγ activation, the master
regulator of adipogenic differentiation, binding to their promoters [12]. In SC cells, the
PPARγ level tended to decrease (p
< 0.1) in 1 and 10µM compared to Cont. In IM cells, the addition
of 10µM of ATRA down-regulated (p < 0.05)
expression of PPARγ compared to Cont. The difference in
C/EBPβ expression may be one of the distinguishing characteristics of IM
adipocytes. The expression of C/EBPβ in preadipocytes is initially low
but dramatically increases during the early stage of terminal differentiation
[13]. PPAR, a member of the nuclear
hormone receptor superfamily, play a significant role in various types of cell
metabolism. Three different PPAR isoforms, PPARγ, PPARa, and PPARd have
been identified. Each of these isoforms is involved in diverse physiological
phenomena [14]. PPARγ plays an
essential role during adipogenic differentiation and simultaneously controls
lipid metabolism-related gene expression. In lipid and glucose metabolism,
synthetic PPARγ ligands, including troglitazone, rosiglitazone, and
pioglitazone, stimulate glucose uptake and improve insulin sensitivity in
adipocytes, hepatocytes, and skeletal muscle cells [11,15]. Adipogenesis
is stimulated upon the activation of PPARγ via ligands, and the mRNA
level of PPARγ increases during bovine SC preadipocyte differentiation
[16,17]. The inhibitory action of ATRA on adipogenic differentiation
seems to be closely related to PPARγ. To regulate the terminal
differentiation of adipose cells, PPARγ must heterodimerize with another
nuclear hormone receptor, RXR [18]. Only
ATRA activates RAR moiety by binding to the ATRA response element, but
9-cis-retinoic acid can bind RXR and RAR [3]. Once ATRA binds to RAR with a high affinity and mediates the
RAR/RXR heterodimer, PPARγ is unable to form the PPAR/RXR heterodimer.
Several researchers have verified this series of PPARγ – involved
adipogenesis blocking processes in recent decades [3,7,8]. To demonstrate the role of ATRA as an
antagonist of RXR-PPARγ heterodimer formation, we tested a RAR
antagonist. The results showed that the RAR antagonist activated
(p < 0.05) PPARγ genes with
ATRA presence while C/EBPβ. RAR antagonist seemed to
accelerate the adipogenic differentiation when the high dose was applied. At the
point that cells were harvested, the expression of PPARγ was mediated by
increased C/EBPβ and C/EBPβ is
started to be downregulated in 10 µM of RAR antagonist treated cells. The
expression of C/EBPβ is rapidly increased in the early
stage of differentiation, and the peak of expression of
C/EBPβ preceded the accumulation of
PPARγ mRNA and then diminished subsequently [11]. This is also confirmed by
morphological analysis. RAR antagonist treatment group showed lipid droplet
accumulation (Figs. 2 and 3). These sequential events transcriptionally
activate genes associated with the adipogenic phenotype [19,20].
Fig. 5.
Expression of adipogenesis-related genes relative to RPS9 in bovine
subcutaneous (SC) adipose cells.
Effect of 0 (control), 0.01, 0.1, 1, and 10 μM of all-trans
retinoic acid (ATRA) on mRNA gene expressions of bovine SC adipocytes.
CCAAT-enhancer-binding proteins beta (CEBPβ), glucose
transporter 4 (GLUT4), lipoprotein lipase (LPL), peroxisome
proliferator activated receptor gamma (PPARγ), stearoyl CoA
desaturase (SCD), SMAD family member 3 (SMAD3) were
measured relative to the quantity of ribosomal protein S9 (RPS9) as the
endogenous control by using the 2−ΔΔCt
method. Superscripts (a–c) denote differences between treatments.
*p < 0.1.
Fig. 4.
Expression of adipogenesis-related genes relative to RPS9 in bovine
intramuscular (IM) adipose cells.
Effect of 0 (control), 0.01, 0.1, 1, and 10 μM of all-trans
retinoic acid (ATRA) on mRNA gene expressions of bovine IM adipocytes.
CCAAT-enhancer-binding proteins beta (CEBPβ), glucose
transporter 4 (GLUT4), lipoprotein lipase (LPL), peroxisome
proliferator activated receptor gamma (PPARγ), stearoyl CoA
desaturase (SCD), SMAD family member 3 (SMAD3) were
measured relative to the quantity of ribosomal protein S9 (RPS9) as the
endogenous control by using the 2−ΔΔCt
method. Superscripts (a–c) denote differences between
treatments.
Fig. 2.
Oil red O (ORO) staining of retinoic acid (1 μM) and retinoic
acid receptor (RAR) antagonist (1 μM) in bovine intramuscular
(IM) and subcutaneous (SC) adipocytes at 96 h post-treatment.
(A) Both IM and SC cells were imaged after 96h of incubation in the
differentiation media (5% fetal bovine serum [FBS], 10 μg/mL
insulin, 10 μg/mL hydrocortisone, 5 μM ciglitizone, and
1× Antibiotic-Antimycotic) with all-trans retinoic acid (ATRA; 1
μM) and RAR antagonist (ANT; 1 μM). Cells were imaged at a
magnification of 200X with a Nikon Eclipse Ti-U microscope. A large
number of lipid droplets were detected in CON and RA+ANT treatment both
in SC and IM adipocytes. (B) ORO and hematoxylin were used to stain
bovine SC and IM adipocytes. After 96 h of incubation in differentiation
media, cells were fixed with 10% formalin. Lipid droplets were stained
with 0.5% ORO. Nuclei were visualized with haematoxylin. Cells were
imaged at a magnification of 200X with a Nikon Eclipse Ti-U microscope.
Bovine SC adipocytes accumulated relatively large lipid droplets, as a
result of droplet-consolidation, compared to IM adipocytes at 96 h of
differentiation. All-trans retinoic acid treated SC and IM adipose cells
showed less lipid droplets compared to CON and RA+20X.
Fig. 3.
Staining of peroxisome proliferator-activated receptor (PPAR)γ
expression and neutral lipid accumulation in bovine subcutaneous (SC)
and intramuscular (IM) adipocytes.
(A) Bovine IM and SC adipocytes were incubated in the differentiation
media (5% fetal bovine serum [FBS], 10 μg/mL insulin,
10μg/mL hydrocortisone, 5 μM ciglitizone, and 1×
Antibiotic-Antimycotic) with all-trans retinoic acid (ATRA; 1 μM)
and retinoic acid receptor (RAR) antagonist (ANT; 1 μM). Nuclei
were stained with 4’,6’-diamidino-2-phenylindole (DAPI,
blue). PPARγ was stained with a rabbit polyclonal anti-PPAR gamma
(green). F-actin was visualized with Bodipy® 558/568
phalloidin (yellow). Slides were imaged at a magnification of 200X using
an inverted fluorescence microscope. For both CON and ATRA+ANT, large
amounts of PPARγ accumulation within nuclei were detected in IM
and SC adipose cells. (B) Nuclei were stained with DAPI (blue). Neutral
lipid droplets were stained with Bodipy® 493/503
(Yellow). Large numbers of neutral lipid droplets were detected in CON
and the ATRA+ANT treated group, both in SC and IM 20X.
Oil red O (ORO) staining of retinoic acid (1 μM) and retinoic
acid receptor (RAR) antagonist (1 μM) in bovine intramuscular
(IM) and subcutaneous (SC) adipocytes at 96 h post-treatment.
(A) Both IM and SC cells were imaged after 96h of incubation in the
differentiation media (5% fetal bovine serum [FBS], 10 μg/mL
insulin, 10 μg/mL hydrocortisone, 5 μM ciglitizone, and
1× Antibiotic-Antimycotic) with all-trans retinoic acid (ATRA; 1
μM) and RAR antagonist (ANT; 1 μM). Cells were imaged at a
magnification of 200X with a Nikon Eclipse Ti-U microscope. A large
number of lipid droplets were detected in CON and RA+ANT treatment both
in SC and IM adipocytes. (B) ORO and hematoxylin were used to stain
bovine SC and IM adipocytes. After 96 h of incubation in differentiation
media, cells were fixed with 10% formalin. Lipid droplets were stained
with 0.5% ORO. Nuclei were visualized with haematoxylin. Cells were
imaged at a magnification of 200X with a Nikon Eclipse Ti-U microscope.
Bovine SC adipocytes accumulated relatively large lipid droplets, as a
result of droplet-consolidation, compared to IM adipocytes at 96 h of
differentiation. All-trans retinoic acid treated SC and IM adipose cells
showed less lipid droplets compared to CON and RA+20X.
Staining of peroxisome proliferator-activated receptor (PPAR)γ
expression and neutral lipid accumulation in bovine subcutaneous (SC)
and intramuscular (IM) adipocytes.
(A) Bovine IM and SC adipocytes were incubated in the differentiation
media (5% fetal bovine serum [FBS], 10 μg/mL insulin,
10μg/mL hydrocortisone, 5 μM ciglitizone, and 1×
Antibiotic-Antimycotic) with all-trans retinoic acid (ATRA; 1 μM)
and retinoic acid receptor (RAR) antagonist (ANT; 1 μM). Nuclei
were stained with 4’,6’-diamidino-2-phenylindole (DAPI,
blue). PPARγ was stained with a rabbit polyclonal anti-PPAR gamma
(green). F-actin was visualized with Bodipy® 558/568
phalloidin (yellow). Slides were imaged at a magnification of 200X using
an inverted fluorescence microscope. For both CON and ATRA+ANT, large
amounts of PPARγ accumulation within nuclei were detected in IM
and SC adipose cells. (B) Nuclei were stained with DAPI (blue). Neutral
lipid droplets were stained with Bodipy® 493/503
(Yellow). Large numbers of neutral lipid droplets were detected in CON
and the ATRA+ANT treated group, both in SC and IM 20X.
Expression of adipogenesis-related genes relative to RPS9 in bovine
intramuscular (IM) adipose cells.
Effect of 0 (control), 0.01, 0.1, 1, and 10 μM of all-trans
retinoic acid (ATRA) on mRNA gene expressions of bovine IM adipocytes.
CCAAT-enhancer-binding proteins beta (CEBPβ), glucose
transporter 4 (GLUT4), lipoprotein lipase (LPL), peroxisome
proliferator activated receptor gamma (PPARγ), stearoyl CoA
desaturase (SCD), SMAD family member 3 (SMAD3) were
measured relative to the quantity of ribosomal protein S9 (RPS9) as the
endogenous control by using the 2−ΔΔCt
method. Superscripts (a–c) denote differences between
treatments.
Expression of adipogenesis-related genes relative to RPS9 in bovine
subcutaneous (SC) adipose cells.
Effect of 0 (control), 0.01, 0.1, 1, and 10 μM of all-trans
retinoic acid (ATRA) on mRNA gene expressions of bovine SC adipocytes.
CCAAT-enhancer-binding proteins beta (CEBPβ), glucose
transporter 4 (GLUT4), lipoprotein lipase (LPL), peroxisome
proliferator activated receptor gamma (PPARγ), stearoyl CoA
desaturase (SCD), SMAD family member 3 (SMAD3) were
measured relative to the quantity of ribosomal protein S9 (RPS9) as the
endogenous control by using the 2−ΔΔCt
method. Superscripts (a–c) denote differences between treatments.
*p < 0.1.
All-trans retinoic acid may affect subcutaneous and intramuscular in a
different manner
In the previous swine study, PPARγ expression was lower in IM adipocytes
than SC or peripheral adipocytes and other genes associated with lipogenesis,
including fatty acid synthase and malic enzyme [21]. It seems evident that IM and SC possess noticeable
characteristics in a lipid metabolic and growth manner. First, IM and SC appear
to utilize different types of substrates for lipogenesis. Smith and Crouse
[22] suggested that carbon sources
for the fatty acid biosynthesis differed across locations in the body; IM
adipocytes preferentially used glucose, while SC adipocytes utilized acetate as
a fuel source. In addition to this, IM adipose tissue used palmitic acid for
triglyceride synthesis, distinctly different from SC adipose tissue [23]. Second, IM adipocytes generally show
less metabolic activities compared to adipocytes in other locations such as SC
and perirenal throughout the animal’s growth [4]. Understanding the physiological characteristics of
adipose cells in different locations, especially IM and SC, is crucial because
this fat depot is directly related to the economic value of beef in many grading
systems [24]. Further studies are
required to develop the feeding strategy to increase IM fat without affecting
the SC fat.
C/EBPβ and SMAD3
The addition of ATRA also tended to modify (p < 0.01)
SMAD3 gene expression in both IM and SC adipocytes. The
role of SMAD3 in the suppression of adipogenic differentiation by ATRA seems
critical. It regulates adipogenesis by altering the expression of C/EBPβ.
Marchildon, St-Louis [25] indicated that
ATRA does not directly regulate C/EBPβ but indirectly stimulates the
expression of the Smad3. They also identified that in the absence of Smad3, ATRA
was not able to inhibit adipocyte differentiation or elicit a decrease in C/EBP.
A disturbance in C/EBPβ binding to DNA response elements in promoters can
occur due to the ability of Smad3 to bind to this bzip transcription factor
[26]. Hence, Smad3 could be another
substance involved in the inhibition of adipogenesis via ATRA. The ATRA
treatment-induced Smad3 protein expression in 3T3-L1 cells regardless of the
co-treatment with the adipogenic mixture used to induce C/EBPβ expression
and differentiation [8].In previous studies, retinoic acid treatments increased plasma triglycerides in
human and rodent models [27,28]. Previous studies demonstrated that
retinoic acid did not directly change LPL mRNA gene expression in 3T3-F442A
[29] and primary adipose cells
isolated from epididymal fat of rats [27]. ATRA may alter LPL activity in adipose tissue; however, it may be
due to the secondary effect of retinoic acid but the direct regulation of the
LPL gene [27]. In agreement with the
previous study, our data from SC cells also indicated that the addition of ATRA
did not alter LPL gene expression. However, the LPL mRNA gene expression was
increased in 10 µM of LPL compared to 0, 0.01, and 0.1 µM of ATRA
treatment (Fig. 5). Blaner and coworkers
[30] reported that retinyl esters are
can be substrates for LPL and suggested that LPL involve in delivering retinol
to adipocytes. However, data related direct effects of ATRA on LPL gene
expression on IM cells is lacking. Additional studies are required.
Stearoyl-CoA Desaturase (SCD)
The ATRA treatment did not alter (p > 0.05) the
expression of SCD in IM cells, but 0.01 µM of ATRA
increased (p < 0.05) SCD in SC cells.
The expression of the SCD gene is considered a later marker in
adipocyte differentiation [26]. Enzyme
activity and SCD gene expression in bovine adipose tissues were
reported as an indicator of fat softness and were an essential aspect of meat
quality [31,32]. Kruk et al. [33] reported that dietary vitamin A restriction elevated SCD activity
and enhanced marbling scores simultaneously in beef cattle. These data provide
additional evidence that SCD activity is highly correlated with marbling scores.
The level of SCD gene expression and SCD enzyme activity is
closely associated with adipocyte differentiation in bovine IM adipose tissue
[34]. In the current study, treatment
of ATRA on IM did not alter the expression of SCD. Because SCD
is considered a late-expression gene among adipogenic markers, 96 h of
incubation in differentiation media may not be long enough to detect changes in
SCD gene expression in IM. Contrary to this, ATRA increased SCD expression in SC
adipocytes. A low concentration (0.01 µM), possibly lower than average
blood retinoic acid concentration, may increase SCD expression in SC
adipocytes.
Glucose transporter 4 (GLUT4)
The transporter associated with glucose uptake in adipose tissue,
GLUT4, gene expression was not affected by ATRA treatment
in IM adipocytes. However, 0.1 µM of ATRA upregulated (p
< 0.05) the expression of GLUT4 in SC cells. A similar
tendency was observed in the studies with the muscle cell. The expression of
GLUT4 mRNA level was upregulated when RA was treated [35,36].Glucose transporter 4 (GLUT4) is the major glucose translocator from the plasma
membrane to intracellular storage that mainly expresses insulin-targeted tissues
such as adipose and muscle tissue. There was no significant difference
(p > 0.05) in gene expression of
GLUT4 in IM adipocytes (Fig.
6). The expression GLUT4 was the greatest (p
< 0.05) in the SC cells when 0.1µM of ATRA was added (Fig. 5). Direct effects of ATRA on GLUT4
activity in adipose cells seemed not clear. There are a few suggested indirect
pathways that ATRA or other vitamin A isoforms have an impact on glucose
transportation in adipose cells. Janke et al. [37] reported that retinol-binding protein 4 (RBP4), the transporter
of retinol, has a positive correlation with GLUT4 in human adipose cells.
Another suggested glucose uptake regulation of ATRA was via RAR signaling in the
pancreas and mediated the insulin secretion [38].
Fig. 6.
Effects of retinoic acid receptor (RAR)-antagonist on
adipogenesis-related gene expressions in bovine intramuscular (IM)
adipose cells.
Effect of 0 (control), 0.01, 0.1, 1, and 10 μM of RAR antagonist
on mRNA gene expressions of bovine IM adipocytes.
CCAAT-enhancer-binding proteins beta (CEBPβ), glucose
transporter 4 (GLUT4), peroxisome proliferator activated receptor
gamma (PPARγ), stearoyl CoA desaturase (SCD), G
protein-coupled receptor 43 (GPR43), SMAD family member 3
(SMAD3) were measured relative to the quantity of ribosomal
protein S9 (RPS9) as the endogenous control by using the
2−ΔΔCt method. Superscripts
(a–c) denote differences between treatments.
Effects of retinoic acid receptor (RAR)-antagonist on
adipogenesis-related gene expressions in bovine intramuscular (IM)
adipose cells.
Effect of 0 (control), 0.01, 0.1, 1, and 10 μM of RAR antagonist
on mRNA gene expressions of bovine IM adipocytes.
CCAAT-enhancer-binding proteins beta (CEBPβ), glucose
transporter 4 (GLUT4), peroxisome proliferator activated receptor
gamma (PPARγ), stearoyl CoA desaturase (SCD), G
protein-coupled receptor 43 (GPR43), SMAD family member 3
(SMAD3) were measured relative to the quantity of ribosomal
protein S9 (RPS9) as the endogenous control by using the
2−ΔΔCt method. Superscripts
(a–c) denote differences between treatments.
CONCLUSION
Vitamin A deficient diet has long been used to improve IM fat contents in beef cattle
in some countries. Our current study demonstrated that adipogenic differentiation
could be blocked by downregulation of the genes such as C/EBPβ (SC cells) and
PPARγ (IM- tendency, SC) when high doses of ATRA were added.In some feeding systems, vitamin A is restricted during the fattening stage. The
standard fattening period for beef cattle lasts more than one-third of the lifespan;
therefore, vitamin A consumption may be restricted for an extended period. Offering
a minimum amount of provitamin or carotene is required to prevent health issues
caused by vitamin A deficiency.
Authors: P García-Rojas; A Antaramian; L González-Dávalos; F Villarroya; A Shimada; A Varela-Echavarría; O Mora Journal: J Anim Sci Date: 2010-02-12 Impact factor: 3.159
Authors: W S Blaner; J C Obunike; S B Kurlandsky; M al-Haideri; R Piantedosi; R J Deckelbaum; I J Goldberg Journal: J Biol Chem Date: 1994-06-17 Impact factor: 5.157